No_RT | RT | Pearson chi-square | ||||
---|---|---|---|---|---|---|
N | % | N | % | P | ||
Totals (n=71) | 28 | 43 | ||||
Sex | Male | 16 | 57.10% | 24 | 55.80% | 0.912 |
Female | 12 | 42.90% | 19 | 44.20% | ||
Race | White | 25 | 89.30% | 40 | 93.00% | 0.458 |
Black | 3 | 10.70% | 2 | 4.70% | ||
Other | 0 | 0.00% | 1 | 2.30% | ||
Stage | 0 | 1 | 3.60% | 1 | 2.30% | 0.584 |
I | 8 | 28.60% | 14 | 32.60% | ||
II | 7 | 25.00% | 9 | 20.90% | ||
III | 9 | 32.10% | 18 | 41.90% | ||
Unknown | 3 | 10.70% | 1 | 2.30% | ||
Cancer diagnosis sequence number | One primary only | 18 | 64.30% | 39 | 90.70% | 0.013 |
1st of 2 or more | 0 | 0.00% | 1 | 2.30% | ||
2nd of 2 or more | 9 | 32.10% | 2 | 4.70% | ||
3rd of 3 or more | 0 | 0.00% | 1 | 2.30% | ||
5th of 5 or more | 1 | 3.60% | 0 | 0.00% | ||
Radiation | None | 27 | 96.40% | 0 | 0.00% | N/A |
Beam radiation | 0 | 0.00% | 43 | 100.00% | ||
Recommended, unknown if administered | 1 | 3.60% | 0 | 0.00% | ||
Surgery | None/Unknown | 14 | 50.00% | 29 | 67.40% | 0.142 |
Surgery given | 14 | 50.00% | 14 | 32.60% | ||
Radiation sequence with surgery | No radiation and/or cancer-directed surgery | 28 | 100.00% | 29 | 67.40% | N/A |
Radiation prior to surgery | 0 | N/A | 2 | 4.70% | ||
Radiation after surgery | 0 | N/A | 12 | 27.90% | ||
Surgery Groups | No/Unknown | 14 | 50.00% | 29 | 67.40% | 0.34 |
Local surgery | 7 | 25.00% | 7 | 16.30% | ||
Extended surgery | 7 | 25.00% | 7 | 16.30% | ||
Reason no cancer-directed surgery | Surgery performed | 14 | 50.00% | 14 | 32.60% | 0.226 |
Not recommended | 10 | 35.70% | 23 | 53.50% | ||
Not recommended, contraindicated due to other conditions | 0 | 0.00% | 2 | 4.70% | ||
Recommended but not performed, unknown reason | 4 | 14.30% | 2 | 4.70% | ||
Recommended but not performed, patient refused | 0 | 0.00% | 1 | 2.30% | ||
Recommended, unknown if performed | 0 | 0.00% | 1 | 2.30% |